Mosaic ImmunoEngineering is a nanotechnology-based immunotherapy company developing therapeutics and vaccines to positively impact the lives of patients and their families.

Free
Message: My take

My take

posted on Dec 08, 2009 02:58PM

Isn’t the strategy here for the MM’s to keep the price

down for the shareholders selling for tax loss purposes.

Seems like this is typical year end action

Share
New Message
Please login to post a reply